N/A
Completed N=60
Conscious Sedation for Epilepsy Surgery
Source: ClinicalTrials.gov NCT02988050 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcomePrimary: Patients Satisfaction — 6.33; 6.45 score on a scale
Summary
Sixty patients were randomly allocated into two groups, group PD and group PR, thirty patients in each group. Patients in PD group received propofol and dexmedetomidine intravenous infusion and patients in PR group received propofol and remifentanil intravenous infusion. Sedation score and patients' satisfaction, surgeon satisfaction, heart rate, mean arterial blood pressure, oxygen saturation, and side effects such as respiratory depression, nausea, vomiting, airway obstruction, and oxygen desaturation were recorded.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patients Satisfaction |
6.33; 6.45 | — |
Eligibility Criteria
Inclusion Criteria
- Patients require conscious sedation for epilepsy surgery
Exclusion Criteria
- Patients refusal, allergy to drugs used, and uncooperative patients.
Data sourced from ClinicalTrials.gov (NCT02988050). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.